In clinical trials, re-consent may be necessary if there are protocol changes or new findings that affect participants. E-consent platforms streamline this process by enabling immediate communication with participants, offering updated consent forms digitally, and tracking their responses in real time. This eliminates delays and ensures that participants remain fully informed, compliant, and able to continue the trial without unnecessary interruptions or confusion.